KURA KURA ONCOLOGY
Permanent stock page ↗Health Care · Russell 2000
Next earnings: Tue 10 Nov 2026 · after market close
What 25 analyst firms say about KURA ONCOLOGY: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
18 rated views · 26 analyst/firm records · 25 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8075
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8059
Recent analyst activity · last 90 days
Our tracked history has 14 reports on KURA from 13 analyst firms in the last 90 days (25 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 5 left it unchanged and 4 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Wedbush raised its target from $36.00 (set 28 Jul 2026) to $38.00 on 13 Aug 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Barclays | Etzer Darout | Buy | 28 Jul 2026 | 24.00 USD |
| Bernstein | Unnamed analyst | — | 15 Jun 2026 | 24.00 USD |
| Brookline Capital Markets | Leah R Cann | Buy | 27 Jul 2026 | 76.00 USD |
| Cantor Fitzgerald | Li Watsek | Buy | 14 Oct 2026 | — |
| Citigroup | Unnamed analyst | Buy | 14 Oct 2026 | — |
| Citizens JMP | Reni Benjamin | Buy | 24 Aug 2026 | 24.00 USD |
| CLSA | Unnamed analyst | — | 4 Jun 2026 | 24.00 USD |
| Deutsche Bank | Unnamed analyst | — | 14 Oct 2026 | 24.00 USD |
| Guggenheim | Bradley P Canino | Hold | 7 Mar 2026 | — |
| H.C. Wainwright | Joseph Pantginis | Buy | 13 Aug 2026 | 40.00 USD |
| Jefferies | Roger Song | Buy | 22 May 2026 | 28.00 USD |
| JPMorgan | Priyanka Grover | Buy | 1 Oct 2026 | 30.00 USD |
| Lake Street Capital Markets | Daniel Brims | Buy | 14 Apr 2026 | 23.00 USD |
| Leerink Partners | Asthika Goonewardene | Buy | 21 Jul 2026 | 28.00 USD |
| Lifesci Capital | Charles Zhu | Buy | 4 Jun 2026 | 28.00 USD |
| Mizuho | Mara Goldstein | Buy | 24 Mar 2026 | 25.00 USD |
| Mizuho | Salim Syed | Buy | 31 Aug 2026 | 25.00 USD |
| Morgan Stanley | Unnamed analyst | — | 24 Aug 2026 | 24.00 USD |
| Oppenheimer | Unnamed analyst | — | 28 May 2026 | 24.00 USD |
| Raymond James | Unnamed analyst | — | 24 Aug 2026 | 24.00 USD |
| TD Cowen | Philip M Nadeau | Buy | 24 Mar 2026 | — |
| UBS | David Dai | Buy | 5 Oct 2026 | 15.00 USD · 21 Aug 2026 |
| Wedbush | Robert Driscoll | Buy | 13 Aug 2026 | 38.00 USD |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| Wells Fargo | Unnamed analyst | — | 4 Jun 2026 | 24.00 USD |
| Data feed RESEARCH | Research Team | Hold | 26 Feb 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:08 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.